A surprising backup system in the immune response to mRNA vaccines may hold the key to more effective cancer treatments.
The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel Prize–winning technology is being adapted to fight cancer, with mRNA vaccines in ...
The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel-prize–winning technology is being adapted to fight cancer, with mRNA vaccines in ...
The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel-prize–winning technology is being adapted to fight cancer, with mRNA vaccines in ...
EDITOR’S NOTE: This story was reported in collaboration with the Global Health Reporting Center with support from the Pulitzer Center. Vita Sara Blechner’s life changed on a Saturday afternoon. The ...
I n December 2020, mRNA vaccines leapt into the limelight as a response to the COVID-19 pandemic. To date, millions of people ...
DNA vaccines represent a versatile platform in which plasmid DNA encoding the SARS-CoV-2 spike antigen is delivered into host cells to elicit both antibody-mediated and T cell-mediated immunity. Rapid ...
A personalized messenger RNA (mRNA) vaccine for pancreatic cancer continues to show promise for improving patient survival, according to 6-year follow-up results of a phase 1 clinical study. Among the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results